Why the study?
Does intensive systolic blood pressure lowering reduce cardiovascular events in hypertensive adults free of diabetes and CVD across different levels of metabolic health?
Population
7,299 hypertensive adults free of diabetes and baseline cardiovascular disease from the SPRINT trial, mean…
Comparison
Intensive systolic blood pressure lowering vs Standard systolic blood pressure lowering
Design
Cohort, Randomized to intensive treatment or standard treatment, Open-label…
Follow-up
median 3.22 years
Key result
Metabolically unhealthy status was associated with a significantly higher risk of cardiovascular events (HR 1.27) compared to metabolically healthy status among hypertensive adults free of diabetes and cardiovascular disease.
Authors
Loading...
May support consistent CV benefit from intensive BP lowering across metabolic health; leaves open confirmation in RCTs.
Cohort (n=7,299)
Open-label
Randomized
Yes
Does intensive systolic blood pressure lowering reduce cardiovascular events in hypertensive adults free of diabetes and CVD across different levels of metabolic health?
Hazard Ratio: 1.27 (95% CI 1.03–1.57)
Absolute Event Rate: 6.4% vs 5.8%
p-value: p=0.024
Intensive systolic blood pressure lowering to <120 mmHg provides consistent cardiovascular protection in hypertensive adults without diabetes or baseline CVD, regardless of their underlying metabolic health status.
Cheon et al. (2026) conducted a cohort in Hypertension (n=7,299). Metabolically unhealthy (MUH) status vs. Metabolically healthy (MH) status was evaluated on Composite of myocardial infarction, acute coronary syndrome, stroke, heart failure, and cardiovascular death (HR 1.27, 95% CI 1.03-1.57, p=0.024). Metabolically unhealthy status was associated with a significantly higher risk of cardiovascular events (HR 1.27) compared to metabolically healthy status among hypertensive adults free of diabetes and cardiovascular disease.